Clinical Trial Update: Comparison of Insulin Detemir Produced by the Current Process and the NN729 Process in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study in healthy subjects comparing insulin detemir produced by the current manufacturing process with insulin detemir produced by the NN729 process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Insulin Detemir (Levemir) (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED